PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24025K1006 — EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 MARCH

EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 MARCH is a federal award for Department of Veterans Affairs (VA) held by MCKESSON CORPORATION. Estimated value $1000M ($1000M obligated). Current period of performance ends Mar 31, 2025. Place of performance: IRVING, TX.

$1000M
Estimated Value
Mar 31, 2025
PoP End / Expires

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

MCKESSON CORPORATION holds $32.0B across 6,790 federal awards, concentrated at Department of Veterans Affairs (VA). PoP ended Mar 31, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Contract facts

Federal
Contract number36C24025K1006
AgencyDepartment of Veterans Affairs (VA)
IncumbentMCKESSON CORPORATION
UEIS1RUKWWRYFL6
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36W79720D0001
Place of performanceIRVING, TX
PoP end (current)Mar 31, 2025
Obligated$1000M

EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 MARCH

Recompete timing

Public
Past PoP end (503 days ago)

Current PoP ended Mar 31, 2025 (503 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Watch this contract — one email →

Incumbent footprint

Public record

MCKESSON CORPORATION$32.0B obligated across 6,790 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($32.0B) · all agencies
Department of Veterans Affairs (VA)$30.8B · 96%Department of Justice (DOJ)$617.6M · 2%Department of Health and Human Services (HHS)$535.6M · 2%Department of Homeland Security (DHS)$9.3M · 0%
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open MCKESSON CORPORATION’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 36C24025K1006?

36C24025K1006 (EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 MARCH) is a Department of Veterans Affairs (VA) award with an estimated value of $1000M, currently held by MCKESSON CORPORATION. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 36C24025K1006?

MCKESSON CORPORATION is the incumbent with $32.0B across 6790 related awards in SCOUT’s public footprint. The current period of performance ends Mar 31, 2025.

When does 36C24025K1006 come up for recompete?

SCOUT tracks a period-of-performance end of Mar 31, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36W79720D0001-36C24025K1006